Pharmaxis Announces A$7.2m Placement and A$2.0m Share Purchase Plan

17th Nov 21

Release Date: 17/11/2021 10:10am


  • A$7.2m being raised in an oversubscribed placement to institutional and sophisticated investors
  • Strong support from existing major shareholders together with new institutional shareholders joining the register
  • Strong pro-forma cash balance post raising  
  • Strengthened balance sheet to support next phase of clinical trials in bone cancer, liver cancer and wound and burns scarring  
  • Issue price of A$0.105 represents a 12.0% discount to the 5-day VWAP of $0.119
  • Share purchase plan to raise approximately $2.0 million to eligible shareholders

Read full media release - pdf

Categories: News and Media